-+ 0.00%
-+ 0.00%
-+ 0.00%

ClearPoint Neuro Narrows FY2026 Sales Guidance from $48.000M-$52.000M to $48.000M-$50.000M vs $49.000M Est

Benzinga·10/28/2026 20:08:42
Listen to the news
ClearPoint Neuro (NASDAQ:CLPT) narrows FY2026 sales outlook from $48.000 million-$52.000 million to $48.000 million-$50.000 million vs $49.000 million estimate.